skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Uses of monoclonial antibody 8H9

Abstract

This invention provides an antibody that binds the same antigen as that of monoclonal antibody 8H9, wherein the heavy chain CDR (Complementary Determining Region)1 comprises NYDIN, heavy chain CDR2 comprises WIFPGDGSTQY, heavy chain CDR3 comprises QTTATWFAY, and the light chain CDR1 comprises RASQSISDYLH, light chain CDR2 comprises YASQSIS, and light chain CDR3 comprises QNGHSFPLT. In another embodiment, there is provided a polypeptide that binds the same antigen as that of monoclonal antibody 8H9, wherein the polypeptide comprises NYDIN, WIFPGDGSTQY, QTTATWFAY, RASQSISDYLH, YASQSIS, and QNGHSFPLT.

Inventors:
Issue Date:
Research Org.:
Sloan-Kettering Institute for Cancer Research, New York, NY (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1185299
Patent Number(s):
9,062,110
Application Number:
13/858,234
Assignee:
Sloan-Kettering Institute for Cancer Research (New York, NY)
DOE Contract Number:  
FG02-93ER61658
Resource Type:
Patent
Resource Relation:
Patent File Date: 2013 Apr 08
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Cheung, Nai-Kong V. Uses of monoclonial antibody 8H9. United States: N. p., 2015. Web.
Cheung, Nai-Kong V. Uses of monoclonial antibody 8H9. United States.
Cheung, Nai-Kong V. Tue . "Uses of monoclonial antibody 8H9". United States. https://www.osti.gov/servlets/purl/1185299.
@article{osti_1185299,
title = {Uses of monoclonial antibody 8H9},
author = {Cheung, Nai-Kong V.},
abstractNote = {This invention provides an antibody that binds the same antigen as that of monoclonal antibody 8H9, wherein the heavy chain CDR (Complementary Determining Region)1 comprises NYDIN, heavy chain CDR2 comprises WIFPGDGSTQY, heavy chain CDR3 comprises QTTATWFAY, and the light chain CDR1 comprises RASQSISDYLH, light chain CDR2 comprises YASQSIS, and light chain CDR3 comprises QNGHSFPLT. In another embodiment, there is provided a polypeptide that binds the same antigen as that of monoclonal antibody 8H9, wherein the polypeptide comprises NYDIN, WIFPGDGSTQY, QTTATWFAY, RASQSISDYLH, YASQSIS, and QNGHSFPLT.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2015},
month = {6}
}

Patent:

Save / Share:

Works referenced in this record:

Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry
journal, January 1993

  • Papanastassiou, V.; Pizer, Bl; Coakham, Hb
  • British Journal of Cancer, Vol. 67, Issue 1
  • DOI: 10.1038/bjc.1993.25

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.
journal, March 1994

  • Celis, E.; Tsai, V.; Crimi, C.
  • Proceedings of the National Academy of Sciences, Vol. 91, Issue 6
  • DOI: 10.1073/pnas.91.6.2105

131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II Study
journal, January 1999


Expression of CD44 splice variants in human primary brain tumors
journal, December 1995

  • Kaaijk, Patricia; Troost, Dirk; Morsink, Folkert
  • Journal of Neuro-Oncology, Vol. 26, Issue 3
  • DOI: 10.1007/BF01052621

Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas
journal, November 1993

  • Moriuchi, S.; Shimizu, K.; Miyao, Y.
  • British Journal of Cancer, Vol. 68, Issue 5
  • DOI: 10.1038/bjc.1993.441

Human Glioma-Specific Antigens Detected by Monoclonal Antibodies
journal, January 1992


Monoclonal antibody against human glioblastoma multiforme (U-87MG) immunoprecipitates a protein of molecular mass 38 kDa and inhibits tumor growth in nude mice
journal, January 1995


Monoclonal antibody against ependymoma-derived cell line
journal, January 1992

  • Mihara, Yosuke; Matsukado, Yasuhiko; Goto, Satoshi
  • Journal of Neuro-Oncology, Vol. 12, Issue 1
  • DOI: 10.1007/BF00172452

Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes.
journal, September 1993

  • Yang, H. Y.; Lieska, N.; Glick, R.
  • Proceedings of the National Academy of Sciences, Vol. 90, Issue 18
  • DOI: 10.1073/pnas.90.18.8534

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

  • Köhler, G.; Milstein, C.
  • Nature, Vol. 256, Issue 5517, p. 495-497
  • DOI: 10.1038/256495a0

The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y
journal, June 1991


Radioimmunotherapy with alpha-emitting nuclides
journal, September 1998

  • McDevitt, Michael R.; Sgouros, George; Finn, Ronald D.
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 25, Issue 9
  • DOI: 10.1007/s002590050306

Phage Library-derived Human Anti-TETA and Anti-DOTA ScFv for Pretargeting RIT
journal, February 1999

  • DeNARDO, Sally J.; DeNARDO, Gerald L.; Brush, Jennifer
  • Hybridoma, Vol. 18, Issue 1
  • DOI: 10.1089/hyb.1999.18.13

Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes
journal, August 1998

  • Krause, Anja; Guo, Hong-Fen; Latouche, Jean-Baptiste
  • The Journal of Experimental Medicine, Vol. 188, Issue 4
  • DOI: 10.1084/jem.188.4.619

Characteristics of the cell surface antigen, p72, associated with a variety of human tumours and mitogen-stimulated T-lymphoblasts
journal, June 1984


Detection of Prostatic Specific Membrane Antigen Messenger RNA Using Immunobead Reverse Transcriptase Polymerase Chain Reaction
journal, January 1999


Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma
journal, November 1998


Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor
journal, July 1990


A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2
journal, May 1991

  • Mujoo, Kalpana; Reisfeld, Ralph A.; Cheung, Lawrence
  • Cancer Immunology Immunotherapy, Vol. 34, Issue 3
  • DOI: 10.1007/BF01742313

Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells
journal, March 1995

  • Holzer, Ursula; Bethge, Wolfgang; Krull, Frauke
  • Cancer Immunology Immunotherapy, Vol. 41, Issue 2
  • DOI: 10.1007/BF01527409

Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients
journal, January 1995

  • Uttenreuther-Fischer, Martina M.; Huang, Chuin-Sheng; Reisfeld, Ralph A.
  • Cancer Immunology Immunotherapy, Vol. 41, Issue 1
  • DOI: 10.1007/BF01788957

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a
journal, May 1992

  • Handgretinger, Rupert; Baader, Peter; Dopfer, Roland
  • Cancer Immunology Immunotherapy, Vol. 35, Issue 3
  • DOI: 10.1007/BF01756188

Diagnostic imaging of human neuroblastoma with radiolabeled antibody.
journal, November 1986


Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
journal, February 1996

  • Grant, Stefan C.; Kostakoglu, Lale; Kris, Mark G.
  • European Journal of Nuclear Medicine, Vol. 23, Issue 2
  • DOI: 10.1007/BF01731837

Disialoganglioside GD2 anti-idiotypic monoclonal antibodies
journal, May 1993

  • Cheung, Nai-Kong V.; Canete, Adela; Cheung, Irene Y.
  • International Journal of Cancer, Vol. 54, Issue 3
  • DOI: 10.1002/ijc.2910540324

Radionuclide photon dose kernels for internal emitter dosimetry
journal, May 1996

  • Furhang, Eli E.; Sgouros, George; Chui, Chen-Shou
  • Medical Physics, Vol. 23, Issue 5
  • DOI: 10.1118/1.597670

A Monte Carlo approach to patient-specific dosimetry
journal, September 1996

  • Furhang, Eli E.; Chui, Chen-Shou; Sgouros, George
  • Medical Physics, Vol. 23, Issue 9
  • DOI: 10.1118/1.597882

Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy
journal, July 1997

  • Furhang, E. E.; Chui, C. S.; Kolbert, K. S.
  • Medical Physics, Vol. 24, Issue 7
  • DOI: 10.1118/1.598018

Common Musculoskeletal Tumors of Childhood and Adolescence
journal, July 1999


Detection of (11; 22)(q24;q12) Translocation-Bearing Cells in Peripheral Blood Progenitor Cells of Patients With Ewing's Sarcoma Family of Tumors
journal, March 1995

  • Toretsky, J. A.; Neckers, L.; Wexler, L. H.
  • JNCI Journal of the National Cancer Institute, Vol. 87, Issue 5
  • DOI: 10.1093/jnci/87.5.385

High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors
journal, December 1997

  • Chan, Kw; Petropoulos, D.; Choroszy, M.
  • Bone Marrow Transplantation, Vol. 20, Issue 12
  • DOI: 10.1038/sj.bmt.1701014

Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours
journal, August 1999

  • Fischmeister, G.; Zoubek, A.; Jugovic, D.
  • Bone Marrow Transplantation, Vol. 24, Issue 4
  • DOI: 10.1038/sj.bmt.1701924

Autologous stem cell transplantation for high-risk pediatric solid tumors
journal, September 1999

  • Perentesis, Jp; Katsanis, E.; DeFor, Te
  • Bone Marrow Transplantation, Vol. 24, Issue 6
  • DOI: 10.1038/sj.bmt.1701950

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
journal, November 1979

  • Chirgwin, John M.; Przybyla, Alan E.; MacDonald, Raymond J.
  • Biochemistry, Vol. 18, Issue 24
  • DOI: 10.1021/bi00591a005

Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy
journal, June 1997


Clinical Applications of CD34 + Peripheral Blood Progenitor Cells (PBPC)
journal, March 2000


Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas
journal, August 1992


Intra-abdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural, and flow cytometric study
journal, August 1993


Desmoplastic Small Round Cell Tumor: II: An Ultrastructural and Immunohistochemical Study with Emphasis on New Immunohistochemical Markers
journal, January 1998


Biotechnological and gene therapeutic strategies in cancer treatment
journal, June 1995


Functional expression of chimeric receptor genes in human T cells
journal, February 2001


Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene
journal, August 1994


Impact of chimeric immune receptor extracellular protein domains on T cell function
journal, March 1999


Efficient Discrimination between Different Densities of Target Antigen by Tetracycline-Regulatable T Bodies
journal, March 1999


In vivo tracking of tumor-specific T cells
journal, April 2001

  • Yee, Cassian; Riddell, Stanley R.; Greenberg, Philip D.
  • Current Opinion in Immunology, Vol. 13, Issue 2, p. 141-146
  • DOI: 10.1016/S0952-7915(00)00196-5

T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients
journal, February 1996

  • Riddell, Stanley R.; Elliott, Mark; Lewinsohn, Deborah A.
  • Nature Medicine, Vol. 2, Issue 2
  • DOI: 10.1038/nm0296-216

The intergroup rhabdomyosarcoma study-II
journal, March 1993


Role of High-Dose Chemotherapy With Hematopoietic Stem Cell Rescue in the Treatment of Metastatic or Recurrent Rhabdomyosarcoma
journal, January 2001


Targeted radioimmunotherapy for leptomeningeal cancer using 131I-3F8
journal, January 2000


Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues
journal, September 2000


The Diagnostic Utility of Desmin: A Study of 584 Cases and Review of the Literature
journal, March 1990

  • Truong, Luan D.; Rangdaeng, Samreung; Cagle, Philip
  • American Journal of Clinical Pathology, Vol. 93, Issue 3
  • DOI: 10.1093/ajcp/93.3.305

Intergroup Rhabdomyosarcoma Study: Update for Pathologists
journal, November 1998

  • Qualman, Stephen J.; Coffin, Cheryl M.; Newton, William A.
  • Pediatric and Developmental Pathology, Vol. 1, Issue 6
  • DOI: 10.1007/s100249900076

Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells
journal, November 1997


New monoclonal antibodies specific for human sarcomas
journal, July 1986

  • Bruland, Øyvind; Fodstad, Øystein; Funderud, Steinar
  • International Journal of Cancer, Vol. 38, Issue 1
  • DOI: 10.1002/ijc.2910380106

Immunocytokines: A Promising Approach to Cancer Immunotherapy
journal, December 1998


Hexabrachion Protein (Tenascin, Cytotactin, Brachionectin) in Connective Tissues, Embryonic Brain, and Tumors
journal, January 1988


Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
journal, April 1988

  • Cheung, N. K.; Walter, E. I.; Smith-Mensah, W. H.
  • Journal of Clinical Investigation, Vol. 81, Issue 4
  • DOI: 10.1172/JCI113426

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma
journal, January 1995


Surface Antigen Expression and Complement Susceptibility of Differentiated Neuroblastoma Clones
journal, March 2000

  • Chen, Shaohua; Caragine, Theresa; Cheung, Nai-Kong V.
  • The American Journal of Pathology, Vol. 156, Issue 3, p. 1085-1091
  • DOI: 10.1016/S0002-9440(10)64976-0

Yttrium-90 biodistribution by yttrium-87 imaging: A theoretical feasibility analysis
journal, August 1998


Multimodality Diagnostics and Megatherapy in Poor Prognosis Ewing's Tumor Patients
journal, October 1999

  • Laws, Hans-Jürgen; Burdach, Stefan; van Kaik, Birgitt
  • Strahlentherapie und Onkologie, Vol. 175, Issue 10
  • DOI: 10.1007/s000660050059

Radiotherapy and High-Dose Chemotherapy in Advanced Ewing's Tumors
journal, October 1999

  • Pape, Hildegard; Laws, Hans-Jürgen; Burdach, Stefan
  • Strahlentherapie und Onkologie, Vol. 175, Issue 10
  • DOI: 10.1007/s000660050058

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors
journal, November 1999


Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
journal, January 1993


SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2
journal, January 1994

  • De Leij, Lou; Helrich, Wijnand; Stein, Rhona
  • International Journal of Cancer, Vol. 57, Issue S8
  • DOI: 10.1002/ijc.2910570713

The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
journal, November 1997

  • Lee, Sean Bong; Kolquist, Kathryn Ann; Nichols, Kim
  • Nature Genetics, Vol. 17, Issue 3
  • DOI: 10.1038/ng1197-309